Oncology Activities
Managed Care Perspectives on Targeted Therapies for Hepatocellular Carcinoma (HCC)
0290-0000-19-163-H01-P
This webinar will educate managed care professionals and pharmacists on the patient populations at highest risk, current and emerging treatment options for HCC, as well as its impact on patient outcomes and costs in a managed care setting.
1.00
Directions in Oncology Pharmacy 2019
Directions in Oncology Pharmacy 2019 will provide education to pharmacists practicing in the oncology clinic, hospital, and specialty pharmacy settings.
10-05-2019
6.75
Integration of PARP Inhibitors for the Treatment of Ovarian Cancer: Significance for Payers and Specialty Pharmacies
0290-0000-19-108-H01-P
This program will analyze approved PARP inhibitor therapies for ovarian cancer through applied knowledge of clinical trial data, mechanisms of action, and adverse effect profiles.
1.50
Chronic Lymphocytic Leukemia: Evolving Treatment Strategies and the Role of the Specialty Pharmacist in Improving Patient Outcomes
0290-0000-19-099-H01-P
This free CE will explain the role of the pharmacist in improving adherence and disease outcomes in patients receiving CLL therapy.
1.50